PXD060574-1

PXD060574 is an original dataset announced via ProteomeXchange.

Title	The profiling of extracellular vesicle subtypes in Huntington’s disease brains identifies Alix as a novel marker of neuropathology
Description	Background: Huntington’s disease (HD) is an inherited autosomal dominant disorder characterized by progressive degeneration of the striatum and cerebral cortex, caused by a mutation in the huntingtin gene, which includes an aberrant expansion of a CAG repeat. The mutant huntingtin protein accumulates in endosomal compartments and alters the endosomal-lysosomal system, which can affect the production, secretion, and content of exosomes - extracellular vesicles (EVs) with an endosomal origin. Therefore, we investigated whether the levels and content of small EV subpopulations, including exosomes, are altered in the brains of HD patients. Methods: We isolated and characterized the proteome of two subtypes of small EVs from the striatum and cortex of HD brains with early or advanced degeneration, as well as from control brains, using differential ultracentrifugation followed by a high-resolution iodixanol density gradient and mass spectrometry analysis. Additionally, we explored the secretion of EVs by fibroblasts from HD patients compared to controls. Results: Our data indicate that the level of Annexin A2-enriched EVs increased in the HD cortex, whereas the level of Alix-enriched EVs was reduced in both the HD striatum and cortex compared to controls. In terms of content per EV, we found that the level of Annexin A2 and Alix were increased and reduced in HD, respectively. This altered cargo of Alix in EVs paralleled a progressive decrease in Alix protein in the cortex and striatum of HD patients, which correlated with the neuropathological state of the brain. Furthermore, in vitro, HD fibroblasts secreted EVs that were less enriched in Alix as compared to control fibroblasts, despite showing similar Alix protein levels in the cell lysates. Conclusions: Taken together, our data provide new insights into the pathophysiology of brain EVs in HD, identifying Alix as a novel marker of neuropathology. This opens new avenues to explore Alix as a potential biomarker of disease progression in peripheral tissues.
HostingRepository	PRIDE
AnnounceDate	2025-12-10
AnnouncementXML	Submission_2025-12-10_03:46:48.181.xml
DigitalObjectIdentifier
ReviewLevel	Peer-reviewed dataset
DatasetOrigin	Original dataset
RepositorySupport	Unsupported dataset by repository
PrimarySubmitter	Eva Borràs
SpeciesList	scientific name: Homo sapiens (Human); NCBI TaxID: NEWT:9606;
ModificationList	No PTMs are included in the dataset
Instrument	Orbitrap Eclipse

Revision	Datetime	Status	ChangeLog Entry
0	2025-02-07 01:38:16	ID requested
⏵ 1	2025-12-10 03:46:49	announced

P, é, rez-Gonz, á, lez R, V, á, zquez-Oliver A, Salvat-Rovira N, Mart, í, nez-Horta S, Rivas-Asensio E, Borr, à, s E, Ortu, ñ, o-Miquel S, S, á, nchez-Carcel, é, n M, Garcia-Forn M, Sampedro F, P, é, rez-P, é, rez J, Sabid, ó E, P, é, rez-Navarro E, Kulisevsky J, The profiling of extracellular vesicle subtypes in Huntington's disease brains identifies Alix as a novel marker of neuropathology. Acta Neuropathol Commun, ():(2025) [pubmed]

10.1186/s40478-025-02187-6;

submitter keyword: mass spectrometry, extracellular vesicles,Huntington’s disease

Eduard Sabido
contact affiliation	CRG/UPF
contact email	eduard.sabido@crg.eu
lab head
Eva Borràs
contact affiliation	UPF
contact email	eva.borras@upf.edu
dataset submitter

Dataset FTP location NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/12/PXD060574

PRIDE project URI

• PRIDE
  1. PXD060574
     1. Label: PRIDE project
     2. Name: The profiling of extracellular vesicle subtypes in Huntington’s disease brains identifies Alix as a novel marker of neuropathology